Zoetis Inc (ZOE MU) stock market data APIs
€100.7012
0(0%)
as of March 20, 2026
Try our APIs with
free plan!
Zoetis Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ZOE.MU.
Prev. Close
100.7012
Open
100.7012
High
100.7012
Low
100.7012
52 wk Range
99.5726-149.7185
Market Cap
96 963 M
Dividends (Yield)
0.0115
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zoetis Inc data using free add-ons & libraries
Get Zoetis Inc Fundamental Data
Zoetis Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zoetis Inc News
New
Wall Street Analysts See Zoetis (ZTS) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ahead, the branded pharmaceutical industry...
What Makes Zoetis (ZTS) an Investment Bet?
Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fourth quarter posted anot...
Zoetis Cuts Guidance As Librela Safety Questions Test Growth Story
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Zoetis (NYSE:ZTS) reduced its full year guidance after raising safety concerns aroun...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
